Coherus Oncology Inc (CHRS)

Net Margin

-257.10%

TTM · Period ending:

CHRS logo

CHRS Net Margin

Latest reported-257.10%
CHRS TTM Net Margin (-1949.65% → -257.10%)
High-resolution chart · PNG

CHRS net margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Coherus Oncology Inc Net Margin — Trailing twelve months (TTM)
Period endingNet Margin
-257.1011%
-323.4883%
-403.8011%
-219.8318%
-111.613%
-66.2986%
14.8316%
-0.196%
-12.5718%
-26.1047%
-92.4772%
-102.8602%
-145.1772%
-148.0119%
-138.2445%
-116.5431%
-83.4674%
-69.2407%
-87.9189%
-63.715%
-41.8617%
-17.2304%
27.7926%
33.0627%
37.1102%
33.4156%
25.229%
-5.1633%
-97.7682%
-498.8032%
-14,888.1004%
-15,306.5553%
-11,042.6667%
-73.8923%
-76.8526%
-66.9821%
-52.044%
-591.6149%
-677.5704%
-743.1843%
-759.4282%
-387.6693%
-308.1873%
-280.1164%
-280.8667%
-836.8871%
-1,197.4491%
-1,949.6547%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.